tci Medicare Compliance & Reimbursement - 2020 Issue Q2
Reader Question: Know These Coding Options for COVID-19 Quandaries
Subscribe or sign in to view the full article.
Article Overview
This reader Q&A explains early guidance from CDC, CMS, and WHO on how to approach COVID-19-related coding during the initial outbreak period. It is relevant to coders, billers, compliance staff, and clinical documentation teams who needed to track rapidly changing federal guidance for diagnosis, exposure, and testing-related reporting. The article also references official coding resources and pricing guidance tied to laboratory testing.
Why This Topic Matters
During the early pandemic, coding guidance changed quickly and affected diagnosis assignment, exposure reporting, and test billing. Articles like this help coding professionals stay aligned with current government instructions and official reference materials.
What You Will Learn
- Which federal organizations issued early COVID-19 coding guidance
- How the article frames diagnosis coding for confirmed coronavirus cases
- How suspected exposure and confirmed exposure scenarios are discussed
- What guidance is summarized for COVID-19 laboratory testing codes
- Which official coding resources and pricing references are mentioned
Who Should Read This
- Medical coders
- Coding auditors
- Billing specialists
- Compliance professionals
- Revenue cycle staff
- Clinical documentation staff
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com